Mavens Biotech standalone Jun '15 sales at Rs 0.20 crore
Mavens Biotech has reported a sales total income from operations of Rs 0.20 crore and a net profit of Rs 0.04 crore for the quarter ended Jun '15
August 13, 2015 / 11:39 AM IST
| Mavens Biotech has reported a standalone total income from operations of Rs 0.20 crore and a net profit of Rs 0.04 crore for the quarter ended Jun '15. | | For the quarter ended Jun 2014 the standalone total income from operations was Rs 0.25 crore and net profit was Rs 0.04 crore. | | Mavens Biotech shares closed at 0.66 on August 12, 2015 (BSE) and has given -2.94% returns over the last 6 months and -32.65% over the last 12 months. |
|
| | Mavens Biotech | | Standalone Quarterly Results | -------- in Rs. Cr. -------- |
|
| Jun '15 | Mar '15 | | | Jun '14 | | Net Sales/Income from operations | 0.20 | 0.40 | | | 0.25 | | Other Operating Income | -- | -- | | | -- | | Total Income From Operations | 0.20 | 0.40 | | | 0.25 | | EXPENDITURE | | | | | | | Consumption of Raw Materials | -- | -- | | | -- | | Purchase of Traded Goods | -- | -- | | | -- | | Increase/Decrease in Stocks | -- | -- | | | -- | | Power & Fuel | -- | -- | | | -- | | Employees Cost | 0.05 | 0.06 | | | 0.06 | | Depreciation | 0.04 | 0.15 | | | 0.04 | | Excise Duty | -- | -- | | | -- | | Admin. And Selling Expenses | -- | -- | | | -- | | R & D Expenses | -- | -- | | | -- | | Provisions And Contingencies | -- | -- | | | -- | | Exp. Capitalised | -- | -- | | | -- | | Other Expenses | 0.08 | 0.18 | | | 0.13 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | 0.04 | 0.01 | | | 0.01 | | Other Income | -- | -- | | | 0.03 | | P/L Before Int., Excpt. Items & Tax | 0.04 | 0.01 | | | 0.04 | | Interest | -- | -- | | | -- | | P/L Before Exceptional Items & Tax | 0.04 | 0.01 | | | 0.04 | | Exceptional Items | -- | -- | | | -- | | P/L Before Tax | 0.04 | 0.01 | | | 0.04 | | Tax | -- | -- | | | -- | | P/L After Tax from Ordinary Activities | 0.04 | 0.01 | | | 0.04 | | Prior Year Adjustments | -- | -- | | | -- | | Extra Ordinary Items | -- | -- | | | -- | | Net Profit/(Loss) For the Period | 0.04 | 0.01 | | | 0.04 | | Equity Share Capital | 10.99 | 10.99 | | | 10.99 | | Reserves Excluding Revaluation Reserves | -- | -- | | | -- | | Equity Dividend Rate (%) | -- | -- | | | -- | | EPS Before Extra Ordinary | | | | | | | Basic EPS | -- | -- | | | -- | | Diluted EPS | -- | -- | | | -- | | EPS After Extra Ordinary | | | | | | | Basic EPS | -- | -- | | | -- | | Diluted EPS | -- | -- | | | -- | | Public Share Holding | | | | | | | No Of Shares (Crores) | 7.47 | 7.47 | | | 7.47 | | Share Holding (%) | 67.96 | 67.96 | | | 67.96 | | Promoters and Promoter Group Shareholding | | | | | | | a) Pledged/Encumbered | | | | | | | - Number of shares (Crores) | -- | -- | | | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | | | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | | | -- | | b) Non-encumbered | | | | | | | - Number of shares (Crores) | 3.52 | 3.52 | | | 3.52 | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | 100.00 | 100.00 | | | 100.00 | | - Per. of shares (as a % of the total Share Cap. of the company) | 32.04 | 32.04 | | | 32.04 | | Source : Dion Global Solutions Limited |
|
Explained | Can US President Donald Trump’s impeachment drag down Wall Street? Watch more 
ITR 2019-20: Income tax refund not received yet? Here are ways to check status Watch more 
Ideas For Profit | Bharat Dynamics: Do robust order book, compelling valuations make it a good bet? Watch more 
Post-COVID-19 Job market | Hiring rises across board, digital roles see high demand: Report Watch more 
